March 11, 2026 · Form 4 insider transaction
Espinoza Octavio bought 2,405 shares of Ligand Pharmaceuticals Incorporated at $92.65 per share, a transaction worth $222.8K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
The transactions reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 19, 2025, in accordance with Rule 10b5-1.